IP Library Granted Patent US 11,667,619
Granted Patent B2
US 11,667,619 · App. 16/921,465 · Granted Jun 6, 2023

Synthesis and purification of cannabinol from cannabidiol

Inventors: Tyler D'Spain (Parker, CO); Melanie Hopek (Thornton, CO); Coleman Wenzl (Niwot, CO)
Assignee: GAIA BOTANICALS LLC
C07D311/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,667,619
App. No.
16/921,465
Granted
Jun 6, 2023
Kind
B2
Abstract

A method to prepare cannabinol (CBN) from derived cannabidiol (CBD) is disclosed. The CBD can be derived from hemp and reacted with a halogen, leading to the cyclization and aromatization of CBD to CBN. The removal of halogen is improved via selective solvent exchange. CBN is isolated from the reaction mixture by use of orthogonal chromatography techniques to provide CBN of high purity.

Claims (15)

1. A method for producing and purifying cannabinol (CBN) from cannabidiol (CBD) comprising the steps of:

dissolving CBD in a solvent;

reacting CBD with a halogen to cyclize and aromatize the CBD to CBN and create a reaction mixture;

decreasing the solubility of said iodine by solvent exchanging said reaction mixture with an alkane to decrease solubility of the halogen; and

purifying of CBN from said reaction mixture by normal phase chromatography and reversed phase chromatography to yield purified CBN.

2. The method of claim 1 , wherein said solvent is toluene.

3. The method of claim 2 , wherein said halogen is iodine.

4. The method of claim 1 , wherein said alkane comprises heptane.

5. The method of claim 1 , wherein said normal phase chromatography is performed on silica gel stationary phase with heptane-ethyl acetate mobile phase.

6. The method of claim 5 , wherein said reversed phase chromatography is performed on C18 silica gel with methanol-water mobile phase.

7. The method of claim 6 wherein said reversed phase chromatography is performed after said normal phase chromatography.

8. The method of claim 6 , wherein said reversed phase chromatography comprises a diluent for column loading consisting of dimethylformamide.

9. The method of claim 8 wherein said CBD is derived from hemp.

10. The method of claim 1 , wherein the purified CBN has a purity of at least 95%.

11. The method of claim 1 , wherein the alkane is selected from the group consisting of pentane, hexane, cyclohexane, heptane, or any mixture thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2026
From: GAIA BOTANICALS, LLC
To: CBDMD, INC.
Reel/Frame 074292/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2021
From: THIRD PARTY VALIDATION & VERIFICATION LLC
To: CBD CLINILABS LLC
Reel/Frame 058463/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2021
From: CBD CLINILABS LLC
To: GAIA BOTANICALS LLC DBA BLUEBIRD BOTANICALS
Reel/Frame 058464/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2021
From: THIRD PARTY VALIDATION & VERIFICATION LLC
To: CBD CLINILABS LLC
Reel/Frame 056753/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2020
From: D'SPAIN, TYLER, MR; WENZL, COLEMAN, MR; HOPEK, MELANIE, MS
To: THIRD PARTY VALIDATION & VERIFICATION LLC
Reel/Frame 053889/0880 →
Continuity (1)
Related Publication 20220002261A1 · Jan 6, 2022